← All companies

TNYA

Tenaya Therapeutics, Inc.

TNYA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.73

-0.01 -1.49%

Key statistics

from XBRL data in SEC filings

Market cap

$158M

Revenue (TTM)

—

Net income (TTM)

-$83.0M

EPS (TTM)

$-0.44

P/E ratio

—

Dividend yield

—

Free cash flow

-$68.9M

Cash

$80.9M

Total assets

$135M

Gross margin

—

52-week range

$0.53 – $2.35

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Terminated a material agreement Jul 2, 2026 8-K Director or officer change; Regulation FD disclosure Jun 29, 2026 8-K Director or officer change; Shareholder vote results May 29, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 11, 2026 8-K Results of operations (earnings release) Mar 11, 2026 8-K Entered a material agreement Mar 5, 2026 8-K Delisting notice or listing-rule failure; Director or officer change Jan 30, 2026 8-K Director or officer change Jan 2, 2026 8-K Entered a material agreement; Regulation FD disclosure Dec 12, 2025 8-K Regulation FD disclosure; Other events Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Other events Nov 7, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results May 30, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Delisting notice or listing-rule failure Apr 18, 2025 8-K Exit or disposal costs Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 10, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Mar 4, 2025 8-K Director or officer change Feb 7, 2025 8-K Director or officer change Jan 28, 2025 8-K Regulation FD disclosure; Other events Dec 17, 2024 8-K Director or officer change Dec 17, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Director or officer change Aug 8, 2024 8-K Director or officer change Jul 25, 2024 8-K Director or officer change Jun 27, 2024 8-K Shareholder vote results May 31, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release); Exit or disposal costs May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 18, 2024